Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)-Health Disparities Subcommittee (HDS), 61505 [2010-24911]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 192 / Tuesday, October 5, 2010 / Notices
international standards, as an
instrumental and essential prerequisite
to the establishment and effective
implementation of adequate and
appropriate legislation covering all
aspects of products for veterinary use,
including registration, quality control,
distribution, monitoring of quantities
and final use.
• Develop and improve international
and regional cooperation in the
establishment and enforcement of
legislation to harmonize the regulatory
framework between OIE Member States
so as to assist countries in need to
effectively institute and maintain such
mechanisms.
• Encourage countries to allocate
appropriate human and financial
resources to veterinary services and
laboratories to correctly implement the
OIE standards and guidelines related to
veterinary products and their control.
• Enhance capacities of national focal
points for OIE on matters related to
veterinary products according to the
suggested terms of reference and
encourage his/her participation in
training sessions and appropriate
international gatherings and meetings.
• Promote the responsible and
prudent use of veterinary medicinal
products, in particular of antimicrobials
used in veterinary medicine, and the
monitoring of the quantities used and
potential existence or development of
antimicrobial resistance in diseasecausing organisms affecting both
humans and animals.
• Actively encourage the recognition
and application of the international
recommendations, guidelines and tools
developed by the OIE and adopted by
the World Assembly of Delegates on
veterinary products.
C. Eligibility Information
The following organizations/
institutions are eligible to apply: The
OIE.
II. Award Information/Funds Available
mstockstill on DSKH9S0YB1PROD with NOTICES
A. Award Amount
FDA anticipates providing one award
of $565,000 (total costs including
indirect costs) in fiscal year (FY) 2010
in support of this project. Subject to the
availability of funds and successful
performance, 1 additional year of
support up to $565,000 per year will be
available.
preceding year, receipt of a noncompeting continuation application and
available Federal FY appropriations.
Dated: September 29, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010–24905 Filed 10–4–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Listing of Members of the
National Institutes of Health’s Senior
Executive Service 2010 Performance
Review Board (PRB)
The National Institutes of Health
(NIH) announces the persons who will
serve on the National Institutes of
Health’s Senior Executive Service 2010
Performance Review Board. This action
is being taken in accordance with Title
5, U.S.C., 4314(c)(4), which requires that
members of performance review boards
be appointed in a manner to ensure
consistency, stability, and objectivity in
performance appraisals and requires
that notice of the appointment of an
individual to serve as a member be
published in the Federal Register.
The following persons will serve on
the NIH Performance Review Board,
which oversees the evaluation of
performance appraisals of NIH Senior
Executive Service (SES) members:
Ms. Colleen Barros (Chair), Dr. Michael
Gottesman, Ms. Lenora Johnson, Ms.
Robin Kawazoe, Dr. Sally Rockey, Dr.
Lawrence Tabak, Dr. Samir Zakhari.
For further information about the NIH
Performance Review Board, contact the
Office of Human Resources, Workforce
Relations Division, National Institutes of
Health, Building 31, Room B3C07,
Bethesda, Maryland 20892, telephone
301–402–9203 (not a toll-free number).
Dated: September 27, 2010.
Francis S. Collins,
Director, National Institutes of Health.
[FR Doc. 2010–24929 Filed 10–4–10; 8:45 am]
BILLING CODE 4140–01–P
The support will be 1 year with the
possibility of an additional year of
noncompetitive support. Continuation
beyond the first year will be based on
satisfactory performance during the
18:36 Oct 04, 2010
Jkt 223001
PO 00000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC)—Health Disparities
Subcommittee (HDS)
Correction: This notice was published
in the Federal Register on September 1,
2010, Volume 75, Number 169, page
53703. A quorum of the subcommittee’s
membership was not able to participate;
therefore, the meeting was adjourned.
The subcommittee will reconvene as
follows:
Time and Date: 2 p.m.–3 p.m.,
October 21, 2010.
Place: Teleconference.
Status: Open to the public.
Teleconference access limited only by
the availability of telephone ports. The
public is welcome to participate during
the public comment period, which is
tentatively scheduled from 2:45 p.m. to
2:50 p.m. To participate in the
teleconference please dial (877) 394–
7734 and enter conference code
9363147.
Purpose: The Subcommittee will
provide recommendations for
consideration to the ACD on strategic
and other broad issues facing CDC.
Matters To Be Discussed: Policy brief
on health equity and social
determinants of health; update on
collaboration with the CDC Health
Equity Workgroup; CDC Director’s
Annual Health Disparity Report; and
briefing on the realignment of the CDC
Office of Minority Health and Health
Disparities. Agenda items are subject to
change as priorities dictate.
Contact Person for More Information:
Walter W. Williams, M.D., M.P.H.,
Designated Federal Officer, HDS, ACD,
CDC, 1600 Clifton Road, NE., M/S E–67,
Atlanta, Georgia 30333. Telephone (404)
498–2310, E-mail: https://
www1@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: September 29, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
B. Length of Support
VerDate Mar<15>2010
61505
[FR Doc. 2010–24911 Filed 10–4–10; 8:45 am]
BILLING CODE 4163–18–P
Frm 00095
Fmt 4703
Sfmt 9990
E:\FR\FM\05OCN1.SGM
05OCN1
]]>Agencies
[Federal Register Volume 75, Number 192 (Tuesday, October 5, 2010)]
[Notices]
[Page 61505]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-24911]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director (ACD), Centers for Disease
Control and Prevention (CDC)--Health Disparities Subcommittee (HDS)
Correction: This notice was published in the Federal Register on
September 1, 2010, Volume 75, Number 169, page 53703. A quorum of the
subcommittee's membership was not able to participate; therefore, the
meeting was adjourned. The subcommittee will reconvene as follows:
Time and Date: 2 p.m.-3 p.m., October 21, 2010.
Place: Teleconference.
Status: Open to the public. Teleconference access limited only by
the availability of telephone ports. The public is welcome to
participate during the public comment period, which is tentatively
scheduled from 2:45 p.m. to 2:50 p.m. To participate in the
teleconference please dial (877) 394-7734 and enter conference code
9363147.
Purpose: The Subcommittee will provide recommendations for
consideration to the ACD on strategic and other broad issues facing
CDC.
Matters To Be Discussed: Policy brief on health equity and social
determinants of health; update on collaboration with the CDC Health
Equity Workgroup; CDC Director's Annual Health Disparity Report; and
briefing on the realignment of the CDC Office of Minority Health and
Health Disparities. Agenda items are subject to change as priorities
dictate.
Contact Person for More Information: Walter W. Williams, M.D.,
M.P.H., Designated Federal Officer, HDS, ACD, CDC, 1600 Clifton Road,
NE., M/S E-67, Atlanta, Georgia 30333. Telephone (404) 498-2310, E-
mail: http://www1@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Dated: September 29, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2010-24911 Filed 10-4-10; 8:45 am]
BILLING CODE 4163-18-P
